Month: October 2013

Medicines Co’s blood thinner Angiomax, when administered en route to the hospital to patients suffering a serious heart attack, significantly reduced the risk of major bleeding and death compared with commonly used heparin, according to data from a large clinical trial. The rate was 5.1 percent in the Angiomax group versus 8.4 percent for those who got heparin, which researchers said was highly statistically significant. “The benefit was early and sustained at 30 days,” said Dr. Philippe Steg, lead investigator of the Euromax study, who presented the findings on Wednesday at the Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting in San Francisco. A secondary goal, added second heart attacks to the composite of death and major bleeding.

JERUSALEM (AP) — Israeli drug manufacturer Teva Pharmaceuticals Ltd. announced Wednesday its CEO had resigned, following a public uproar over a contentious restructuring plan set to cut thousands of jobs worldwide.

WASHINGTON (AP) — No one knows how often the youngest athletes suffer concussions. It's not clear if better headgear is the answer, and it's not just a risk in football.

WASHINGTON (AP) — Defending President Barack Obama's much-maligned health care overhaul in Congress, his top health official was confronted Wednesday with a government memo raising new security concerns about the trouble-prone website that consumers are using to enroll.

ABOARD AIR FORCE ONE (Reuters) – President Barack Obama has full confidence in embattled Health and Human Services Secretary Kathleen Sebelius, who told Congress on Thursday that she is responsible for the “debacle” of the roll out of the health care web site. “The president has complete confidence in Secretary Sebelius,” White House spokesman Josh Earnest told reporters traveling with the president. (Reporting By Roberta Rampton and Mark Felsenthal; editing by Jackie Frank)